Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8662531 | International Journal of Cardiology | 2018 | 8 Pages |
Abstract
Late Gadolinium Enhancement (LGE) in CMR predicts all-cause mortality, cardiovascular mortality, ventricular arrhythmia and sudden death, and major adverse cardiovascular events, independent of LVEF. Future trials of investigational therapies in NICM and ICM should consider the utilization of LGE to identify patients at risk of adverse outcomes.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Anand N. Ganesan, James Gunton, Gaetano Nucifora, Andrew D. McGavigan, Joseph B. Selvanayagam,